Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: Dosing studies in different age groups

Vaccine

Volumn 24, Issue 10, 2006, Pages 1726-1733

  Qadri, Firdausi ^a   Ahmed, Tanvir ^a   Ahmed, Firoz ^a   Begum, Yasmin Ara ^a   Sack, David A ^a   Svennerholm, Ann Mari ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dosing; Enterotoxigenic Escherichia coli (ETEC) vaccine; Immunogenicity; Infants and children; Safety

Indexed keywords

CHOLERA TOXIN B SUBUNIT; ENTEROTOXIGENIC ESCHERICHIA COLI PLUS CHOLERA TOXIN B SUBUNIT VACCINE; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ANOREXIA; ANTIBODY TITER; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; LOOSE FECES; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANTIBODIES, BACTERIAL; CHOLERA TOXIN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; ESCHERICHIA COLI VACCINES; FEMALE; HUMANS; INFANT; MALE; PILOT PROJECTS; VACCINES, ATTENUATED;

EID: 32544432509     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.110     Document Type: Article

References (23)

1. World Health Organization New frontiers in the development of vaccines against enterotoxinogenic (ETEC) and enterohaemorrhagic (EHEC) E. coli infections. Part I Wkly Epidemiol Rec 74 13 1999 98 101
2. R.E. Black, M.H. Merson, I. Huq, A.R. Alim, and M. Yunus Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development Lancet 1 8212 1981 141 143
3. A.M. Svennerholm, C. Ahren, and M. Jertborn Oral inactivated vaccines against enterotoxigenic Escherichia coli M.M. Levine G.C. Woodrow J.B. Kaper G.S. Gabon New Generation Vaccines 2nd ed. 1997 Marcel Dekker Inc New York 865 874
4. M.M. Levine, and A.M. Svennerholm Enteric vaccines: Present and future HL. DuPont H. Steffen Textbook of travel medicine and health 2nd ed. 2001 BC Deker Inc. 252 263
5. A.M. Svennerholm, and D. Steele Microbial-gut interactions in health and disease. Progress in enteric vaccine development Best Pract Res Clin Gastroenterol 18 2 2004 421 445
6. S.J. Savarino, F.M. Brown, E. Hall, S. Bassily, F. Youssef, and T. Wierzba Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults J Infect Dis 177 3 1998 796 799
7. S.J. Savarino, E.R. Hall, S. Bassily, F.M. Brown, F. Youssef, and T.F. Wierzba Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group J Infect Dis 179 1 1999 107 114
8. E.R. Hall, T.F. Wierzba, C. Ahren, M.R. Rao, S. Bassily, and W. Francis Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine Infect Immun 69 5 2001 2853 2857
9. F. Qadri, C. Wenneras, F. Ahmed, M. Asaduzzaman, D. Saha, and M.J. Albert Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children Vaccine 18 24 2000 2704 2712
10. S.J. Savarino, E.R. Hall, S. Bassily, T.F. Wierzba, F.G. Youssef, and L.F. Peruski Jr. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants Pediatr Infect Dis J 21 4 2002 322 330
11. F. Qadri, T. Ahmed, F. Ahmed, R.B. Sack, D.A. Sack, and A.M. Svennerholm Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age Vaccine 21 2003 2394 2403
12. Qadri F, Ahmed T, Ahmed F, Begum YA, Sack DA, Svennerholm AM, et al. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants and children. http://203.190.254.12/images/ascodd2003_ss13_Reduced.pdf.
13. C. Ahren, C. Wenneras, J. Holmgren, and A.M. Svennerholm Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine Vaccine 11 9 1993 929 934
14. J. Sanchez, and J. Holmgren Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development Proc Natl Acad Sci USA 86 2 1989 481 485
15. M. Jertborn, C. Ahren, J. Holmgren, and A.M. Svennerholm Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine Vaccine 16 2-3 1998 255 260
16. A.M. Svennerholm, J. Holmgren, R. Black, M. Levine, and M. Merson Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli J Infect Dis 147 3 1983 514 522
17. C. Wenneras, A.M. Svennerholm, C. Ahren, and C. Czerkinsky Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Infect Immun 60 7 1992 2605 2611
18. C. Czerkinsky, Z. Moldoveanu, J. Mestecky, L.A. Nilsson, and O. Ouchterlony A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells J Immunol Methods 115 1 1988 31 37
19. F. Qadri, S.K. Das, A.S. Faruque, G.J. Fuchs, M.J. Albert, and R.B. Sack Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh J Clin Microbiol 38 1 2000 27 31
20. M. Jertborn, C. Ahren, and A.M. Svennerholm Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine Clin Diagn Lab Immunol 8 2 2001 424 428
21. D.L. Murdoch, K. Goa, and D.P. Figgit Combined Hepatitis A and B vaccines: A review of their immunogenicity and toleratibility Drugs 63 23 2003 2625 2649
22. E. Weir Influenza in children CMAJ 169 1 2003 1052
23. Centers for Disease Control Prevention (CDC) Inactivated Japanese Encephalitis virus vaccine recommendations of the advisory committee on common immunization practices MMWR Morb Mortal Wkly Rep 1993 42 (RR-01)